Selected research
Industry Research
Polymers Drug Delivery Industry Research Report 2026
Market perspective
The global Polymers Drug Delivery market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Polymers Drug Delivery market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Polymers Drug Delivery market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Polymers Drug Delivery market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Polymers Drug Delivery include Eisai, Sanofi, Johnson & Johnson, Vectura Group Plc, Tolmar, SurModics, Quark Pharmaceuticals Inc, Perrigo and Nektar Therapeutics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Polymers Drug Delivery market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Polymers Drug Delivery.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Polymers Drug Delivery Market by Company
Eisai
Sanofi
Johnson & Johnson
Vectura Group Plc
Tolmar
SurModics
Quark Pharmaceuticals Inc
Perrigo
Nektar Therapeutics
Janssen Biotech
Inovio Pharmaceuticals
Heron
Gilead Sciences
Enzon Pharmaceuticals
EnColl Corporation
Allergan
Alkermes
Polymers Drug Delivery Segment by Type
Micelles
Dendrimer
Hydrogels
Microgels
Other
Polymers Drug Delivery Segment by Application
Medical Research Center
Pharmaceutical Factory
Other
Polymers Drug Delivery Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymers Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymers Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymers Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Polymers Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Micelles
- Dendrimer
- Hydrogels
- Microgels
- Other
Applications
- Medical Research Center
- Pharmaceutical Factory
- Other
Companies covered
- Eisai
- Sanofi
- Johnson & Johnson
- Vectura Group Plc
- Tolmar
- SurModics
- Quark Pharmaceuticals Inc
- Perrigo
- Nektar Therapeutics
- Janssen Biotech
- Inovio Pharmaceuticals
- Heron
- Gilead Sciences
- Enzon Pharmaceuticals
- EnColl Corporation
- Allergan
- Alkermes
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Polymers Drug Delivery by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Micelles
- 2.2.3 Dendrimer
- 2.2.4 Hydrogels
- 2.2.5 Microgels
- 2.2.6 Other
- 2.3 Polymers Drug Delivery by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Research Center
- 2.3.3 Pharmaceutical Factory
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Polymers Drug Delivery Breakdown Data by Type
- 3.1 Global Polymers Drug Delivery Historic Market Size by Type (2021-2026)
- 3.2 Global Polymers Drug Delivery Forecasted Market Size by Type (2027-2032)
4 Polymers Drug Delivery Breakdown Data by Application
- 4.1 Global Polymers Drug Delivery Historic Market Size by Application (2021-2026)
- 4.2 Global Polymers Drug Delivery Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Polymers Drug Delivery Market Perspective (2021-2032)
- 5.2 Global Polymers Drug Delivery Growth Trends by Region
- 5.2.1 Global Polymers Drug Delivery Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Polymers Drug Delivery Historic Market Size by Region (2021-2026)
- 5.2.3 Polymers Drug Delivery Forecasted Market Size by Region (2027-2032)
- 5.3 Polymers Drug Delivery Market Dynamics
- 5.3.1 Polymers Drug Delivery Industry Trends
- 5.3.2 Polymers Drug Delivery Market Drivers
- 5.3.3 Polymers Drug Delivery Market Challenges
- 5.3.4 Polymers Drug Delivery Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Polymers Drug Delivery Players by Revenue
- 6.1.1 Global Top Polymers Drug Delivery Players by Revenue (2021-2026)
- 6.1.2 Global Polymers Drug Delivery Revenue Market Share by Players (2021-2026)
- 6.2 Global Polymers Drug Delivery Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Polymers Drug Delivery Head Office and Area Served
- 6.4 Global Polymers Drug Delivery Players, Product Type & Application
- 6.5 Global Polymers Drug Delivery Manufacturers Established Date
- 6.6 Global Polymers Drug Delivery Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Polymers Drug Delivery Market Size (2021-2032)
- 7.2 North America Polymers Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Polymers Drug Delivery Market Size by Country (2021-2026)
- 7.4 North America Polymers Drug Delivery Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Polymers Drug Delivery Market Size (2021-2032)
- 8.2 Europe Polymers Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Polymers Drug Delivery Market Size by Country (2021-2026)
- 8.4 Europe Polymers Drug Delivery Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Polymers Drug Delivery Market Size (2021-2032)
- 9.2 Asia-Pacific Polymers Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Polymers Drug Delivery Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Polymers Drug Delivery Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Polymers Drug Delivery Market Size (2021-2032)
- 10.2 South America Polymers Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Polymers Drug Delivery Market Size by Country (2021-2026)
- 10.4 South America Polymers Drug Delivery Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Polymers Drug Delivery Market Size (2021-2032)
- 11.2 Middle East & Africa Polymers Drug Delivery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Polymers Drug Delivery Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Polymers Drug Delivery Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eisai
- 12.1.1 Eisai Company Information
- 12.1.2 Eisai Business Overview
- 12.1.3 Eisai Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.1.4 Eisai Polymers Drug Delivery Product Portfolio
- 12.1.5 Eisai Recent Developments
- 12.2 Sanofi
- 12.2.1 Sanofi Company Information
- 12.2.2 Sanofi Business Overview
- 12.2.3 Sanofi Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.2.4 Sanofi Polymers Drug Delivery Product Portfolio
- 12.2.5 Sanofi Recent Developments
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Information
- 12.3.2 Johnson & Johnson Business Overview
- 12.3.3 Johnson & Johnson Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.3.4 Johnson & Johnson Polymers Drug Delivery Product Portfolio
- 12.3.5 Johnson & Johnson Recent Developments
- 12.4 Vectura Group Plc
- 12.4.1 Vectura Group Plc Company Information
- 12.4.2 Vectura Group Plc Business Overview
- 12.4.3 Vectura Group Plc Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.4.4 Vectura Group Plc Polymers Drug Delivery Product Portfolio
- 12.4.5 Vectura Group Plc Recent Developments
- 12.5 Tolmar
- 12.5.1 Tolmar Company Information
- 12.5.2 Tolmar Business Overview
- 12.5.3 Tolmar Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.5.4 Tolmar Polymers Drug Delivery Product Portfolio
- 12.5.5 Tolmar Recent Developments
- 12.6 SurModics
- 12.6.1 SurModics Company Information
- 12.6.2 SurModics Business Overview
- 12.6.3 SurModics Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.6.4 SurModics Polymers Drug Delivery Product Portfolio
- 12.6.5 SurModics Recent Developments
- 12.7 Quark Pharmaceuticals Inc
- 12.7.1 Quark Pharmaceuticals Inc Company Information
- 12.7.2 Quark Pharmaceuticals Inc Business Overview
- 12.7.3 Quark Pharmaceuticals Inc Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.7.4 Quark Pharmaceuticals Inc Polymers Drug Delivery Product Portfolio
- 12.7.5 Quark Pharmaceuticals Inc Recent Developments
- 12.8 Perrigo
- 12.8.1 Perrigo Company Information
- 12.8.2 Perrigo Business Overview
- 12.8.3 Perrigo Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.8.4 Perrigo Polymers Drug Delivery Product Portfolio
- 12.8.5 Perrigo Recent Developments
- 12.9 Nektar Therapeutics
- 12.9.1 Nektar Therapeutics Company Information
- 12.9.2 Nektar Therapeutics Business Overview
- 12.9.3 Nektar Therapeutics Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.9.4 Nektar Therapeutics Polymers Drug Delivery Product Portfolio
- 12.9.5 Nektar Therapeutics Recent Developments
- 12.10 Janssen Biotech
- 12.10.1 Janssen Biotech Company Information
- 12.10.2 Janssen Biotech Business Overview
- 12.10.3 Janssen Biotech Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.10.4 Janssen Biotech Polymers Drug Delivery Product Portfolio
- 12.10.5 Janssen Biotech Recent Developments
- 12.11 Inovio Pharmaceuticals
- 12.11.1 Inovio Pharmaceuticals Company Information
- 12.11.2 Inovio Pharmaceuticals Business Overview
- 12.11.3 Inovio Pharmaceuticals Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.11.4 Inovio Pharmaceuticals Polymers Drug Delivery Product Portfolio
- 12.11.5 Inovio Pharmaceuticals Recent Developments
- 12.12 Heron
- 12.12.1 Heron Company Information
- 12.12.2 Heron Business Overview
- 12.12.3 Heron Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.12.4 Heron Polymers Drug Delivery Product Portfolio
- 12.12.5 Heron Recent Developments
- 12.13 Gilead Sciences
- 12.13.1 Gilead Sciences Company Information
- 12.13.2 Gilead Sciences Business Overview
- 12.13.3 Gilead Sciences Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.13.4 Gilead Sciences Polymers Drug Delivery Product Portfolio
- 12.13.5 Gilead Sciences Recent Developments
- 12.14 Enzon Pharmaceuticals
- 12.14.1 Enzon Pharmaceuticals Company Information
- 12.14.2 Enzon Pharmaceuticals Business Overview
- 12.14.3 Enzon Pharmaceuticals Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.14.4 Enzon Pharmaceuticals Polymers Drug Delivery Product Portfolio
- 12.14.5 Enzon Pharmaceuticals Recent Developments
- 12.15 EnColl Corporation
- 12.15.1 EnColl Corporation Company Information
- 12.15.2 EnColl Corporation Business Overview
- 12.15.3 EnColl Corporation Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.15.4 EnColl Corporation Polymers Drug Delivery Product Portfolio
- 12.15.5 EnColl Corporation Recent Developments
- 12.16 Allergan
- 12.16.1 Allergan Company Information
- 12.16.2 Allergan Business Overview
- 12.16.3 Allergan Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.16.4 Allergan Polymers Drug Delivery Product Portfolio
- 12.16.5 Allergan Recent Developments
- 12.17 Alkermes
- 12.17.1 Alkermes Company Information
- 12.17.2 Alkermes Business Overview
- 12.17.3 Alkermes Revenue in Polymers Drug Delivery Business (2021-2026)
- 12.17.4 Alkermes Polymers Drug Delivery Product Portfolio
- 12.17.5 Alkermes Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst